ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EMBC vs CLPT // EV/EBITDA & P/E VALUATION

Embecta Corp. (NASDAQ) VS. ClearPoint Neuro Inc. (NASDAQ) • 15-METRIC TALLY: EMBC 8 — CLPT 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. CLPT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EMBC CLPT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.60% 61.40% +1.20 EMBC /gross-margins <GO>
Return on Invested Capital (ROIC) 35.50% -35.00% +70.50 EMBC /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 6.1x — — TIE /valuation <GO>
Free Cash Flow Yield — -7.13% — TIE /fcf-yield <GO>
Operating Margin 22.40% -60.00% +82.40 EMBC /operating-margins <GO>
Net Profit Margin 8.80% -60.00% +68.80 EMBC /net-margins <GO>
Revenue Growth (YoY) -3.80% 17.80% -21.60 CLPT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 9.42% 0.00% +9.42 EMBC /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 4/9 +3.00 EMBC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 52.2 48.9 +3.27 EMBC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 3.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $371.7M $342.7M $29.0M EMBC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EMBC REV CLPT REV EMBC GROSS % CLPT GROSS % EMBC FCF CLPT FCF
FY 2025 $1.08B $37.0M 62.6% 61.4% $182.4M -$24.4M
FY 2024 $1.12B $31.4M 65.5% 60.9% $19.9M -$9.2M
FY 2023 $1.12B $24.0M — — $67.7M -$13.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
CLPT // BETA —